[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"body-temperature\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:body-temperature":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,44,94,120],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100623472","clinical-accuracy-validation-of-the-moni-patch-temperature-monitoring-patch-system-100623472",false,"NCT07397078","Clinical Accuracy Validation of the Moni-Patch Temperature Monitoring Patch System","Moni-Patch Temperature Monitoring Patch System Clinical Accuracy Validation","Inclusion Criteria:\n\n* Age ≥ 7 years\n* Agree to Sensor placement on the neck and ear\n\nExclusion Criteria:\n\n* Ear conditions contraindicating tympanic probe; skin issues at placement sites\n* Antipyretic use within 120 minutes; inability to position neck Sensor over carotid\n* Inability to seal tympanic sensor; tympanic membrane not visually confirmed",true,"ALL","7 Years",{"count":20,"type":21},105,"ESTIMATED","INTERVENTIONAL",[24],"NA","Moni-Patch Temperature Monitoring Patch System, a non-invasive, continuous temperature monitoring device designed to estimate core body temperature by applying a Sensor to the neck.\n\nThis clinical accuracy validation study aims to verify the accuracy and repeatability of the Moni-Patch compared with an FDA-cleared continuous tympanic temperature monitoring device used as the clinical reference.\n\nMain objectives of this study are; To verify that the Moni-Patch and the reference device(tympanic) demonstrate acceptable agreement, as defined by Bland-Altman Analyses (bias within ±0.4°C and limits of agreement between -1.0°C and 1.0°C).\n\nTo verify the consistency and repeatability of temperature measurements obtained from the Moni-Patch during continuous monitoring.",[27,28],"Body Temperature","Febrile",[30],"Core body temperature","NOT_YET_RECRUITING","2026-02-05",{"date":34,"type":35},"2026-02-09","ACTUAL",{"date":37,"type":21},"2026-01-21",{"date":39,"type":21},"2026-03-31",{"name":41,"class":42},"Murata Vios, Inc.","INDUSTRY",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":16,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":4,"briefSummary":58,"conditions":59,"keywords":68,"overallStatus":83,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":43},"100612012","smartphone-vs-manual-interpretation-of-biomarkers-for-ovulation-and-luteal-phase-detection-smom-study-100612012","NCT07248046","Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)","Comparing Cervical Mucus, PDG, LH, and Basal Body Temperature Combinations for Ovulation and Luteal Phase Identification Using the Premom Smartphone App Versus User-Read Test Results: A Prospective Observational Study","SMOM","Inclusion Criteria:\n\n* Female, aged 16 to 45\n* Natural menstrual cycles equal or less than 35 days\n* Off hormonal contraception for more than 3 months\n* Current user of the Premom App\n* Willing to track cervical mucus, LH, PDG, and BBT for 3 full cycles\n* Lives within 50 km of study site in the Ottawa region\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding\n* Current hormonal therapy or contraception\n* Known anovulatory disorders, e.g., Polycystic Ovary Syndrome, hypothalamic amenorrhea.\n* Very irregular or absent cycles\n* Not using the Premom App\n* Unable or unwilling to complete tracking or provide consent","FEMALE","16 Years","45 Years",{"count":56,"type":21},30,"OBSERVATIONAL","This study will compare different combinations of fertility signs (cervical mucus (CM), luteinizing hormone \\[LH\\], pregnanediol glucuronide \\[PDG\\], and basal body temperature \\[BBT\\]) to determine which are most reliable for identifying ovulation and luteal phase length. Thirty existing Premom App users will track daily observations for three menstrual cycles. Participants will record mucus, perform urine tests, upload test strip photos to the Premom App, and measure BBT. Both participant readings and AI-assisted app readings will be analyzed. The main goal is to find which marker pairings give the most accurate picture of ovulation timing and luteal phase length. Secondary goals include understanding ease of use, the number of tests required, and whether the app improves accuracy.",[60,61,62,63,27,64,65,66,67],"Fertility","Mobile Applications","Artifical Intelligence","Cervical Mucus","Luteinizing Hormone (LH)","Ovulation","Menstrual Cycle","Progesterone",[65,69,66,60,63,70,71,67,72,73,74,61,75,76,77,78,79,80,81,82],"Luteal Phase","Luteinizing Hormone","Pregnanediol Glucuronide","Basal Body Temperature","Female Reproductive Physiology","Fertility Awareness-Based Methods","Smartphone App","Artificial Intelligence","Self-Testing","Home Diagnostic Tests","Observational Study","Prospective Studies","Digital Health","Women's Health","RECRUITING","2026-01-10",{"date":86,"type":35},"2026-01-13",{"date":88,"type":21},"2026-01-15",{"date":90,"type":21},"2026-11-15",{"name":92,"class":93},"Bruyère Health Research Institute.","OTHER",{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":98,"acronym":99,"eligibilityCriteria":100,"healthyVolunteers":11,"sex":17,"minAge":101,"maxAge":4,"enrollmentInfo":102,"targetDuration":4,"studyType":57,"phases":4,"briefSummary":104,"conditions":105,"keywords":4,"overallStatus":83,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":43},"100440972","remote-investigation-and-assessment-of-vital-signs-100440972","NCT05022264","Remote Investigation and Assessment of Vital Signs","RIA-VS","Inclusion Criteria:\n\nThe same subject can't be enrolled more than once with the exception that subjects in WP1 may also be recruited to WP2.\n\nWP1+WP2:\n\n1. The patient is attending primary or secondary health care.\n2. The subject has provided informed consent.\n3. Age ≥18 years.\n4. Fluent in Swedish, English, Somali or Arabic (we will translate the patient information and ensure an interpreter can be present for translating questions).\n5. The patient is willing and able to give informed consent \".\n6. The investigator determines that the new study device, and the reference methods, can be used as intended with adequate safety.\n7. The delay in the management of each patient introduced by this study is approximately 15-20 minutes. Patients deemed being in such a severe medical condition that 15-20 minutes of delay is deemed detrimental will not be included.\n\nWP3:\n\n1. Patients attending primary health care.\n2. The subject has provided informed consent.\n3. Age ≥18 years.\n4. Fluent in Swedish, English, Somali or Arabic (we will translate the patient information and ensure an interpreter can be present for translating questions).\n5. The patient is willing and able to give informed consent .\n6. The investigator determines that the new study device, and the reference methods, can be used as intended with adequate safety.\n7. The delay in the management of each patient introduced by this study is approximately 15-20 minutes. Patients deemed being in such a severe medical condition that 15-20 minutes of delay is deemed detrimental will not be included.\n\nExclusion Criteria:\n\nSubjects are free to withdraw from the study at any point. Subjects will also be withdrawn from the study in case of unexpected depressed level of consciousness from inclusion up until all investigations are completed (during approximately 15-20 minutes). Any reduction in consciousness will incur that the subject is withdrawn.","18 Years",{"count":103,"type":21},860,"The vital signs (pulse, systolic and diastolic blood pressure, respiratory rate, oxygen saturation and body temperature) are critical in assessing the severity and prognosis of infections. The devices used today for measuring the vital signs have to be in physical contact with the patients. There is an apparent risk of transferring infections from one patient to the next (or to healthcare professionals). Accurately obtaining vital signs is also important when managing other categories of patients where it may be relevant to obtain some of the vital signs such as pulse and blood pressure.\n\nThis project aims to evaluate a new camera-based system for contactless measurement of vital signs.",[106,107,108,109,27],"Blood Pressure","Pulse Rate","Respiratory Rate","Oxygen Saturation","2025-09-16",{"date":112,"type":35},"2025-09-22",{"date":114,"type":35},"2022-03-01",{"date":116,"type":21},"2027-06-30",{"name":118,"class":119},"Vastra Gotaland Region","OTHER_GOV",{"id":121,"slug":122,"hasResults":11,"nctId":123,"briefTitle":124,"officialTitle":125,"acronym":126,"eligibilityCriteria":127,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":128,"enrollmentInfo":129,"targetDuration":4,"studyType":22,"phases":131,"briefSummary":132,"conditions":133,"keywords":135,"overallStatus":83,"whyStopped":4,"lastUpdateSubmitDate":141,"lastUpdatePostDateStruct":142,"startDateStruct":144,"completionDateStruct":146,"leadSponsor":148,"locationsCount":43},"100356299","air-vs-cutaneous-control-mode-for-preterm-infants--32-wg-in-incubators-impact-on-body-growth-and-morbidity-100356299","NCT03919188","Air vs. Cutaneous Control Mode for Preterm Infants ≤ 32 WG in Incubators: Impact on Body Growth and Morbidity","Comparison of Air vs. Cutaneous Control Mode for Preterm Infants ≤ 32 WG Raised in Closed Incubators: Impact on Body Growth and Morbidity","ThermoKPreterm","Inclusion Criteria:\n\n* preterm infant born between 25+0 and 32+0 weeks of gestation\n* preterm infant included in the study before 24 +\u002F- 12 hours of life\n* preterm infant nursed in a closed incubator\n* written informed consent from his parents\n\nExclusion Criteria:\n\n* newborn infant with polymalformative syndrome\n* life threatening events or serious heart disease","1 Day",{"count":130,"type":21},164,[24],"Previous studies have shown that mortality and morbidity in preterm neonates are correlated with the fall in body temperature on admission. Hypothermia can be decreased by reducing body heat losses to the environment. The investigator research hypothesis is that a new calculation of the air temperature in the incubator would promote the newborn infant weight growth from the period between birth and day 10 of life compared to cutaneous mode. The secondary hypotheses assumes a decrease in the side effects usually observed in both morbidity and mortality.\n\nA software is used to calculate the body heat loss (BHL) of each individual preterm infant, and to propose a specific air temperature setting inside the incubator to reduce BHL to zero. This software has been validated in a previous pilot study (Degorre et al. 2015). This study aims to compare the energy costs of providing incubated preterm infants born between 25 and 32 weeks of gestation with homeothermia using either specific individualized air temperature control (ATC) or skin servocontrol (SSC).",[134,27],"Preterm Infant",[136,137,138,139,140],"preterm neonates","incubator management","body temperature","relative air humidity","thermoneutrality","2025-05-23",{"date":143,"type":35},"2025-05-29",{"date":145,"type":35},"2022-01-01",{"date":147,"type":21},"2025-12",{"name":149,"class":93},"Centre Hospitalier Universitaire, Amiens"]